Results per Page:
Decisions, decisions: factors that impact HCT outcomes in AML
From the Walter Group, Translational Sciences and Therapeutics Division
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
T cell diversity as a measure of immune recovery following CBT
From the Cord Blood Group and colleagues, Clinical Research Division
Prolonged viral prophylaxis helps limit reactivation events after cord blood transplantation
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
Bezos family gives $35 million to Fred Hutch
Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
Fred Hutch holiday gala raises more than $13 million for pediatric cancer research
Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children
Cost of survival: Coping with treatment complications beyond the cure
Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies
New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
'A chance to hope’: Leukemia survivor, family reunite with favorite doctor
Ex-patient’s wife recalls how her sacred mission to save her husband led her to Fred Hutch
A pioneering procedure’s expanding influence
Developed to treat leukemia, stem cell transplants gave rise to new therapies for an ever-growing number of patients and conditions
'How do you say thank you?': Stem cell recipient, donor meet
Stem cell donor, recipient meet each other – and researchers who made transplant possible
Cord blood: 'The biggest blessing ever'
Cord blood: a lifesaving option for those in need of a transplant but cannot find a matched donor